Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Enteral Glutamine in Neurologically-injured Patients

This study has been completed.
Information provided by (Responsible Party):
University of Wisconsin, Madison Identifier:
First received: September 13, 2005
Last updated: September 29, 2015
Last verified: September 2015

September 13, 2005
September 29, 2015
January 2003
January 2008   (final data collection date for primary outcome measure)
Nosocomial infections [ Time Frame: throughout study ] [ Designated as safety issue: Yes ]
Nosocomial infections
Complete list of historical versions of study NCT00204971 on Archive Site
  • Multiple organ dysfunction syndrome [ Time Frame: throughout the study ] [ Designated as safety issue: Yes ]
  • Nutritional outcome parameters [ Time Frame: throughout the study ] [ Designated as safety issue: No ]
  • Multiple organ dysfunction syndrome
  • - Nutritional outcome parameters
Not Provided
Not Provided
Enteral Glutamine in Neurologically-injured Patients
Randomized, Placebo-controlled Clinical Trial of Enteral Glutamine Supplementation in Neurologically-injured Patients
Nutrition is an important part of the recovery process after having a head injury so that subjects can gain strength and fight off infection. Liquid nutrition formulas are often given to patients through a tube that has been placed into the intestines for feeding when they are unable to eat on their own. Some reports suggest that nutrition with extra amounts of the amino acid called glutamine may decrease infections and hospital stay in severely injured patients.The purpose of this study is to evaluate if giving extra amounts of an amino acid called glutamine with liquid nutrition formulas will decrease the risk of infection and length of stay in the intensive care unit after having a head injury.
Not Provided
Phase 4
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Prevention
  • Neurologic Injury
  • Traumatic Brain Injury
  • Dietary Supplement: Enteral glutamine powder
    nutritional supplement
  • Other: placebo
    placebo control
  • Experimental: 1
    Nutritional supplement
    Intervention: Dietary Supplement: Enteral glutamine powder
  • Placebo Comparator: 2
    Intervention: Other: placebo
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
January 2008
January 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Males
  • Nonpregnant females
  • Aged 18-75 years old
  • Glasgow Coma Scores of 3-12
  • Injury Severity Scores greater than or equal to 20
  • Requiring enteral nutrition for a minimum of 5 days

Exclusion Criteria:

  • Documented hepatic dysfunction
  • Acute renal failure (creatinine clearance < 15 mL/min)
  • Gastrointestinal malabsorptive disorder
  • Infection at time of admission
18 Years to 75 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Not Provided
University of Wisconsin, Madison
University of Wisconsin, Madison
Not Provided
Principal Investigator: Gordon S Sacks, PharmD University of Wisconsin, Madison
University of Wisconsin, Madison
September 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP